EVALUATING NURSING CARE FOR MUCOSITIS INDUCED BY CHEMORADIATION FOR THE TREATMENT OF HEAD AND NECK CANCER AT NATIONAL CANCER HOSPITAL

Hùng Kiên Đỗ1,, Thị Huệ Vũ1
1 National Cancer Hospital

Main Article Content

Abstract

Objective: evaluating the efficace of nursing care for mucositis induced by chemoradiotherapy for the treatment of head and neck cancer at National Cancer Hospital. Patients and method: 65 patients were diagnosed of head and neck cancer and treated with chemoradiotherapy at National Cancer Hospital from 03/2022 to 10/2022. Method research was description prospective and cross-section. Results: Male patients were dominated (accounted for 67.7%) with 70.8% of patients less than 65 years old. ECOG 0 was the most common performant status, accounted for 70.1%, then ECOG 1 (69.3%). Most of patients had  history of smoking and/or drinking (72.3%). Major patients was diagnosed of nasopharyngeal cancer (55,4%). The majority of patients had grade 1 and 2 mucositis (accounted for 23.1% and 67.7%, respectively), six patients presented of grade 3. Mild and moderate local pain were most common symptoms, accounted for 35.8% and 58.5%, respectively. The percentage of weight loss < 5% was 43.1% of cases. The most patients were outpatient with education and nursing care, 11 cases presented with grade 3 toxicity and/or combined infections need medical treatment at hospital. Many patients improved mucositis condition after intervention and no report of complications. Conclusion: Mucositis induced by chemoradiotherapy was common adverse events in head and neck cancer. Internal medicine care plays an important role in improving patient’s symptoms and their quality of life, minimizing the treatment interruption.

Article Details

References

1. Pakin DM, Bray F, Ferlay J, et al (2005). Global cancer statistics 2002. CA Cancer J Clin, 55, 2005, 74-108.
2. Nguyễn Bá Đức, Nguyễn Thị Hoài Nga (2007). Dịch tễ học mô tả bệnh ung thư. Chẩn đoán và điều trị ung thư, Nhà xuất bản Y học, 1-15.
3. National Comprehensive Cancer Network. Bone Cancer (Version 1.2022). http://www.nccn.org/professionals/physician_gls/pdf/ head-and-neck.pdf. Accessed February 28, 2022.
4. Common Terminology Criteria for Adverse Events (CTCAE) - CTCAE_v5_Quick_Reference_5x7.pdf. 2017 https://ctep.cancer.gov/protocoldevelopment/electronic_applications/ctc.htm
5. Lalla, R.V.; Bowen, J.; Barasch, A.; Elting, L.; Epstein, J.; Keefe, D.M.; McGuire, D.B.; Migliorati, C.; Nicolatou-Galitis, O.; Peterson, D.E.; et al. MASCC/ISOO Clinical Practice Guidelines for the Management of Mucositis Secondary to Cancer Therapy. Cancer 2014, 120, 1453–1461, doi:10.1002/cncr.28592.
6. Brown, T.J.; Gupta, A. Management of Cancer Therapy–Associated Oral Mucositis. JCO Oncol. Pract. 2020, 16, 103–109, doi:10.1200/JOP.19.00652.
7. Lalla, R.V.; Sonis, S.T.; Peterson, D.E. Management of Oral Mucositis in Patients Who Have Cancer. Dent. Clin. North Am. 2008, 52, 61–viii, doi:10.1016/j.cden.2007.10.002.
8. Araújo, S.N.M.; Luz, M.H.B.A.; da Silva, G.R.F.; Andrade, E.M.L.R.; Nunes, L.C.C.; Moura, R.O. Cancer patients with oral mucositis: challenges for nursing care. Rev Lat Am Enfermagem 2015, 23, 267–274, doi:10.1590/0104-1169.0090.2551.
9. Madan Kumar, P.; Sequeira, P.; Shenoy, K.; Shetty, J. The Effect of Three Mouthwashes on Radiation-Induced Oral Mucositis in Patients with Head and Neck Malignancies: A Randomized Control Trial. Journal of Cancer Research and Therapeutics 2008, 4, 3–8.
10. Bồ Thị Minh Châu, Phạm Thị Quỳnh và cs. Đánh giá chăm sóc điều dưỡng người bệnh xạ trị ung thư đầu-cổ tại khoa Xạ trị Bệnh viện Vimmec Times City. Tạp chí Ung thư học Việt Nam, p316-320.